Peca Labs
Pittsburgh, US · Founded 2012 · Delaware corporation
PECA Labs develops cardiovascular implants—including vascular grafts and the MASA Valve, a polymeric bi-leaflet valved conduit for pulmonary valve reconstruction—based on a proprietary tunable polymeric material platform. Its devices target both pediatric and adult patients, with the MASA Valve currently under investigational use in a U.S. clinical trial.
BiotechHealthtechMedical DevicesNew Materials
Founders & leadership
CD
C. Douglas BernsteinCEO
RK
Rajan KalraDirector
DS
David SmithExecutive Officer
SN
Samuel NavarroDirector
MM
Michael MoriartyDirector
DJ
Dr. Jeffrey CarpenterDirector
JO
Jeff O?DonnellDirector
JK
Jon KuhnDirector
DJ
Dr. Joseph BavariaDirector
BH
Brandon HaynesDirector
BC
Barbara CarryerDirector
Competitors · 4
by search overlapNCT051011875 shared keywords
Diabetes Prevention Program5 shared keywords
Edwards Lifesciences3 shared keywords
Aptus Endosystems3 shared keywordsCardiovascular Business is a news and media outlet covering the cardiology field, publishing reporting on medical devices, treatments, regulatory decisions, and clinical developments for cardiovascular healthcare professionals.
Companies competing with Peca Labs for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$2.7MraisedNov 2025 · 18 investors · Other Health CareRule 506(b)
▶$2.7MraisedNov 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brandon HaynesDirector
- Dr. Joseph BavariaDirector
- Barbara CarryerDirector
- Jon KuhnDirector
- Dr. Jeffrey CarpenterDirector
- Michael MoriartyDirector
- Samuel NavarroDirector
- C. Douglas BernsteinExecutive Officer, Director
- Jeff O?DonnellDirector
- Offering amount
- $5M
- Amount sold
- $2.7M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.9MraisedDec 2024 · 32 investors · Other Health CareRule 506(b)
▶$13.9MraisedDec 2024 · 32 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael MoriartyDirector
- Dr. Jeffrey CarpenterDirector
- Samuel NavarroDirector
- Jeff O?DonnellDirector
- Jon KuhnDirector
- C. Douglas BernsteinExecutive Officer, Director
- Dr. Joseph BavariaDirector
- Brandon HaynesDirector
- Barbara CarryerDirector
- Offering amount
- $16.5M
- Amount sold
- $13.9M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$618.2KraisedNov 2022 · 6 investors · Other Health CareRule 506(b)
▶$618.2KraisedNov 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Barbara CarryerDirector
- Michael MoriartyDirector
- David SmithExecutive Officer
- James BrowneDirector
- Douglas BernsteinExecutive Officer, Director
- Jon KuhnDirector
- Amount sold
- $618.2K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$99.2KraisedJul 2021 · 1 investors · Other Health CareRule 506(b)
▶$99.2KraisedJul 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert DicksonDirector
- Michael MoriartyDirector
- Jon KuhnDirector
- Babs CarryerDirector
- Douglas BernsteinExecutive Officer, Director
- David SmithExecutive Officer
- James BrowneDirector
- Offering amount
- $1.8M
- Amount sold
- $99.2K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$587.5KraisedJun 2020 · 5 investors · Other Health CareRule 506(b)
▶$587.5KraisedJun 2020 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BrowneDirector
- Robert DicksonDirector
- Jon KuhnDirector
- Michael MoriartyDirector
- David SmithExecutive Officer
- Douglas BernsteinExecutive Officer, Director
- Babs CarryerDirector
- Offering amount
- $2.1M
- Amount sold
- $587.5K
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$93.8KraisedFeb 2019 · 1 investors · Other Health CareRule 506(b)
▶$93.8KraisedFeb 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert DicksonDirector
- Michael MoriartyDirector
- James BrowneDirector
- Douglas BernsteinExecutive Officer, Director
- David SmithExecutive Officer
- Jon KuhnDirector
- Babs CarryerDirector
- Offering amount
- $1.6M
- Amount sold
- $93.8K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedFeb 2018 · 4 investors · Other Health CareRule 506(b)
▶$1.4MraisedFeb 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Babs CarryerDirector
- David SmithExecutive Officer
- James BrowneDirector
- Robert DicksonDirector
- Michael MoriartyDirector
- Douglas BernsteinExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedNov 2016 · 5 investors · Other Health CareRule 506(b)
▶$750KraisedNov 2016 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David SmithExecutive Officer
- Michael MoriartyDirector
- Robert DicksonDirector
- Douglas BernsteinExecutive Officer, Director
- Babs CarryerDirector
- James BrowneDirector
- Offering amount
- $750K
- Amount sold
- $750K
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $998K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $149.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.